渗透泵型控释片,osmotic pump controlled-release tablets
1)osmotic pump controlled-release tablets渗透泵型控释片
1.Ketoprofenosmotic pump controlled-release tablets were prepared.制备了酮洛芬渗透泵型控释片,并进行了体外释放度和犬体内药动学试验。
2.In this paper, gastrodin was selected as the model drug to prepare sustained-release tablets(ST),osmotic pump controlled-release tablets(OPT) and sustained-release pellets(SP).本文以天麻素(Gastrodin)为模型药物，制备了天麻素缓释片、渗透泵型控释片，并利用流化床设备制备了天麻素缓释微丸。
英文短句/例句
1.Studies on Metformin Hydrochloride Osmotic Pump Controlled Release Tablets;盐酸二甲双胍渗透泵型控释片的研究
2.Studies on Tramadol Hydrochloride Osmotic Pump Controlled-Release Tablets;盐酸曲马多渗透泵型控释片剂的研究
3.Study on Osmotic Pumping Tablet of Ondansetron Hydrochloride;盐酸昂丹司琼渗透泵型控释片剂的研究
4.Formulation Study on Roxithromycin Osmotic Pump Controlled Release Tablet罗红霉素渗透泵型控释片处方工艺研究
5.Studies on Insoluble Glipizide Osmotic Pump Controlled-Release Tablets and Drug Release Mechanism;难溶性药物格列吡嗪渗透泵型控释片及释药机理的研究
6.Investigation on the preparation and the factors influencing the drug release rate in vitro of osmotic pump tablet of Tandospirone citrate枸橼酸坦度螺酮渗透泵型控释片的制备及体外释药因素的考察
7.Study on Ketoprofen Monolithic Osmotic Pump Controlled-release Tablet;酮基布洛芬单室渗透泵控释片的研究
8.Core formulation optimization of Osmotically Controlled Release Tablets of colchicine秋水仙碱渗透泵控释片的片芯处方设计
9.Study on Valaciclovir Hydrochloride Micro-porous Osmotic Pump Tablets;盐酸万乃洛韦微孔渗透泵控释片的研究
10.Studies on Controlled Porosity Osmotic Pump Tablets of Extract of Lysimachia Clethroide Duby珍珠菜提取物微孔渗透泵控释片的研究
11.Preparation and Pharmacokinetics in Beagle Dogs of Gliclazide Osmotic Pump Controlled-release Tablets格列齐特渗透泵控释片的制备及犬体内药动学
12.Total Flavone of Herba Epimediumon Micro-porous Osmotic Pump Tablets:Preparation and Drug Release Behaviors in Vitro淫羊藿总黄酮微孔渗透泵控释片的制备及体外释药因素的考察
13.Preparation and drug release in vitro of the metformin hydrochloride osmotic pump controlled release tablets盐酸二甲双胍渗透泵控释片的制备及体外释放度考察
14.Preparation and in vitro release of breviscapin two-layer osmotic pump tablets灯盏花素双层渗透泵控释片的制备及体外释放度
15.Drug release in-vitro mathematical model of Panax Notoginoside Micro-porous Osmotic Pump Tablet三七总皂苷微孔型渗透泵片体外释药数学模型的研究
16.Studies on Coating Technique of Aqueous Cellulose Acetate Dispersion Used in Osmotic Pump Tablets;渗透泵控释片醋酸纤维素水分散体包衣技术研究
17.Preparation of nefopam hydrochloride controlled porosity osmotic pump by central composite design中心复合设计法制备盐酸奈福泮微孔渗透泵控释片
18.The bioavilability and pharmacokinetics study of pentoxifylline osmotic pump controlled release tablets in rabbits己酮可可碱渗透泵控释片在家兔体内的药动学和相对生物利用度
相关短句/例句
micro-porous osmotic pump controlled release tablets微孔渗透泵型控释片
3)push-pull osmotically controlled-release tablets推拉型渗透泵控释片
1.Objective: To investigate the feasibility of swelling hydrogel instead of polyethylene oxide as swelling polymer in push-layer ofpush-pull osmotically controlled-release tablets.目的:考察常用亲水膨胀材料替代聚氧乙烯作为推动层的膨胀推动剂用于制备推拉型渗透泵控释片的可行性。
4)osmotic pump controlled release tablets渗透泵控释片
1.Preparation of ambroxol hydrochlorideosmotic pump controlled release tablets;盐酸氨溴索渗透泵控释片的研制
2.Objective To study pharmacokinetics of dogs in vivo of captoprilosmotic pump controlled release tablets.结论渗透泵控释片血药浓度平稳 ,可较长时间保持有效血药浓
3.Objective:To study the in vitro release rate of ambroxol HClosmotic pump controlled release tablets.目的 :研究盐酸氨溴索渗透泵控释片的体外释放度。
5)osmotic pump tablet渗透泵控释片
1.In vitro and in vivo correlation of self-designedosmotic pump tablet of oxybutynin;自制奥昔布宁渗透泵控释片的体内外相关性研究
6)osmotic pump control-released tablets渗透泵控释片剂
1.The drilling requirements in the production of a new type troche,osmotic pump control-released tablets, is the nodus in the research of this kind of medicine.新剂型“渗透泵控释片剂”生产中的打孔要求是目前该类型制剂的研发瓶颈。
延伸阅读
心宁美, 卡比多巴-左旋多巴, 息宁控释片,帕金宁控释片药物名称：息宁英文名：Sinemet别名：息宁、心宁美, 卡比多巴-左旋多巴, 息宁控释片,帕金宁控释片外文名：Carbidopa and Levodopa, Sinemet药理毒理：神经内科用药。本药是卡比多巴(一种芳香氨基酸类脱羧酶抑制剂)与左旋多巴(多巴胺的前体药物)的复合物，是以聚合物为基质的控释片剂。左旋多巴在脑内通过脱羧形成多巴胺而缓解帕金森氏病的症状。不能透过血脑屏障的卡比多巴只抑制外周左旋多巴的脱羧，从而使更多的左旋多巴转运到脑，转化成多巴氨，避免了左旋多巴频繁大剂量给药的必要性。低剂量减少或可能有助于消除胃肠道和心血管系统的副作用，尤其是那些与外周形成多巴胺有关的副作用。控释片在4-6小时内释放出有效成分。本药的血浆左旋多巴水平变化较小。 适应症：震颤麻痹，震颤麻痹综合征。不良反应：常见运动障碍、恶心、呕吐、抑郁、失眠和幻觉等，偶有消化道出血。相互作用：与单胺氧化酶抑制药合用可致血压骤升。吩塞秦、可乐定、罂粟碱、利舍平、苯妥英等可拮抗本品的作用。溴隐亭可增强本品作用。用法用量：口服，0.5～1片/次，2～4次/日，按病情需要逐渐增量，一般每日不超过卡比多巴75mg，左旋多巴750mg。注意事项：妊娠C类。狭角型青光眼、皮肤癌患者禁用。有心、肝、肺、肾、消化道溃疡及精神障碍者慎用。规格：心宁美，(息宁控释片Sinemet)：卡比多巴25mg+左旋多巴100mg、卡比多巴10mg+左旋多巴100mg、卡比多巴50mg+左旋多巴200mg。类别：抗帕金森病药
